Gamma-glutamyltransferase and risk of cardiovascular mortality: A dose-response meta-analysis of prospective cohort studies

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Wang, Junna ^a   Zhang, Dandan ^b   Huang, Rongzhong ^b   Li, Xingsheng ^b   Huang, Wenxiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HAZARD RATIO; HUMAN; SEX DIFFERENCE; BLOOD; FEMALE; MALE; META ANALYSIS; MORTALITY; PROGNOSIS; RISK;

CARDIOVASCULAR DISEASES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; PROGNOSIS; RISK; SEX FACTORS;

EID: 85013684806     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172631     Document Type: Article

References (70)

1. Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA. The contributions of risk factor trends and medical care to cardiovascular mortality trends. Nat Rev Cardiol. 2015;12(9):508-530. doi: 10. 1038/nrcardio.2015.82 PMID: 26076950
2. Dugani S, Gaziano T A. 25 by 25: Achieving Global Reduction in Cardiovascular Mortality. Curr Cardiol Rep. 2016;18(1):1-6.
3. Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, et al. Contribution of six risk factors to achieving the 25× 25 non-communicable disease mortality reduction target: a modelling study. The Lancet. 2014;384(9941):427-437.
4. Whitfield J B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38(4):263-355. doi: 10.1080/20014091084227 PMID: 11563810
5. Rollason J G, Pincherle G, Robinson D. Serum gamma glutamyltranspeptidase in relation to alcohol consumption. Clinica Chimica Acta. 1972;39(1):75-80
6. Bulusu S, Sharma M. What does serum γ-glutamyltransferase tell us as a cardiometabolic risk marker?. Ann Clin Biochem. 2016;53(Pt 3):312-32. doi: 10.1177/0004563215597010 PMID: 26139450
7. Turgut O, Tandogan I. Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward[J]. J Atheroscler Thromb. 2011;18(3):177-181. PMID: 21041983
8. Kunutsor S K, Abbasi A, Adler A I. Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis. Ann Epidemiol. 2014;24(11):809-816. doi: 10. 1016/j.annepidem.2014.09.001 PMID: 25263236
9. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27(1):127-33. doi: 10.1161/01. ATV.0000251993.20372.40 PMID: 17095717
10. Kunutsor S K, Apekey T A, Cheung B MY. Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence. J Hypertens. 2015;33(12):2373-2381. doi: 10.1097/HJH.0000000000000763 PMID: 26485462
11. Daeppen JB, Smith TL, Schuckit MA. Influence of age and body mass index on g-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res. 1998;22:941-4. PMID: 9660326
12. van Barneveld T, Seidell JC, Traag N, Hautvast JG. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year old Dutch males. Eur J Clin Nutr. 1989;43(12):809-18. PMID: 2576402
13. Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, et al. Serum γ-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med. 2005;22(9):1134-40. doi: 10.1111/j.1464-5491.2005.01581.x PMID: 16108838
14. Lee DH, Gross MD, Steffes MW, Jacobs DR Jr. Is serum gamma-glutamyltransferase a biomarker of xenobiotics, which are conjugated by glutathione?. Arterioscler Thromb Vasc Biol. 2008;28(4):e26-8. doi: 10.1161/ATVBAHA.107.159376 PMID: 18354088
15. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28, 838 middle-aged men and women. Eur Heart J. 2006;27(18):2170-6. doi: 10.1093/eurheartj/ehl086 PMID: 16772340
16. Meisinger C, Döring A, Schneider A, Löwel H; KORA Study Group. Serum γ-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis. 2006;189(2):297-302. doi: 10.1016/j.atherosclerosis.2006.01.010 PMID: 16483579
17. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, et al. γ-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults. Circulation. 2005;112(14):2130-7. doi: 10.1161/CIRCULATIONAHA.105.552547 PMID: 16186419
18. Wannamethee S G, Lennon L, Shaper A G. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis. 2008;201(1):168-175. doi: 10.1016/j.atherosclerosis.2008.01.019 PMID: 18378241
19. Breitling LP, Claessen H, Drath C, Arndt V, Brenner H. Gamma-glutamyltransferase, general and cause-specific mortality in 19, 000 construction workers followed over 20 years. J Hepatol. 2011;55(3):594-601. doi: 10.1016/j.jhep. 2010.12.029 PMID: 21256904
20. Kengne AP, Czernichow S, Stamatakis E, Hamer M, Batty GD. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys. J Hepatol. 2012;57(5):1083-1089. doi: 10.1016/j.jhep. 2012.06.034 PMID: 22796154
21. Koehler EM, Sanna D, Hansen BE, van Rooij FJ, Heeringa J, Hofman A, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int. 2014;34(2):296-304. doi: 10. 1111/liv. 12311 PMID: 24219360
22. Sung KC, Ryu S, Kim BS, Cheong ES, Park DI, Kim BI, et al. γ-Glutamyl Transferase Is Associated with Mortality Outcomes Independently of Fatty Liver. Clin Chem. 2015;61(9):1173-81. doi: 10.1373/clinchem.2015.240424 PMID: 26152752
23. Li Y, Iso H, Cui R, Murakami Y, Yatsuya H, Miura K, et al. Serum γ-glutamyltransferase and Mortality due to Cardiovascular Disease in Japanese Men and Women. J Atheroscler Thromb. 2016;23(7):792-9. doi: 10.5551/jat.32698 PMID: 26875518
24. Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology. 2009;50(5):1403-11. doi: 10.1002/hep. 23135 PMID: 19670414
25. Ruhl C E, Everhart J E. Elevated serum alanine aminotransferase and γ-glutamyltransferase and mortality in the United States population. Gastroenterology. 2009;136(2):477-485. e11. doi: 10.1053/j. gastro.2008.10.052 PMID: 19100265
26. Hozawa A, Okamura T, Kadowaki T, Murakami Y, Nakamura K, Hayakawa T, et al. γ-Glutamyltransferase predicts cardiovascular death among Japanese women. Atherosclerosis. 2007;194(2):498-504. doi: 10.1016/j.atherosclerosis.2006.08.058 PMID: 17034795
27. Du G, Song Z, Zhang Q. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies. Prev Med. 2013;57(1):31-7. doi: 10.1016/j. ypmed.2013.03.011 PMID: 23571185
28. Long Y, Zeng F, Shi J, Tian H, Chen T. Gamma-glutamyltransferase predicts increased risk of mortality: A systematic review and meta-analysis of prospective observational studies. Free Radic Res. 2014;48(6):716-28. doi: 10.3109/10715762.2014.902055 PMID: 24684379
29. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-9, W64. PMID: 19622511
30. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
31. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies[J]. Circulation. 2014;129(6):643-59. doi: 10.1161/CIRCULATIONAHA.113.005925 PMID: 24201300
32. Petitti D B. Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. Oxford University Press, 1999.
33. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized doseresponse data. Stata Journal. 2006;6(1):40.
34. Durrleman S, Simon R. Flexible regression models with cubic splines. Statistics in medicine. 1989;8(5):551-561. PMID: 2657958
35. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80(15):1198-202 PMID: 3047407
36. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21(4):589-624. PMID: 11836738
37. Rong Y, Chen L, Zhu T, Song Y, Yu M, Shan Z, et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies[J]. BMJ. 2013;346:e8539. doi: 10.1136/bmj.e8539 PMID: 23295181
38. Wallin A, Orsini N, Wolk A. Red and processed meat consumption and risk of ovarian cancer: a doseresponse meta-analysis of prospective studies. Br J Cancer. 2011;104(7):1196-201 doi: 10.1038/bjc. 2011.49 PMID: 21343939
39. Higgins J, Thompson S G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558 doi: 10.1002/sim.1186 PMID: 12111919
40. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. PMID: 3802833
41. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 2008;61:991-6. doi: 10.1016/j.jclinepi.2007.11.010 PMID: 18538991
42. Begg C B, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101. PMID: 7786990
43. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34. PMID: 9310563
44. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake analysis of the British women's heart and health study and meta-analysis. Arterioscler Thromb Vasc Biol. 2007;27(12):2729-35. doi: 10. 1161/ATVBAHA.107.152298 PMID: 17932318
45. D O e Silva E R, Foster D, M G Harper M, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins AI and A-II. Circulation, 2000, 102(19):2347-2352. PMID: 11067787
46. Chen J T, Kotani K. Serum γ-glutamyltranspeptidase and oxidative stress in subjectively healthy women: an association with menopausal stages. Aging Clin Exp Res. 2016;28(4):619-24. doi: 10. 1007/s40520-015-0460-y PMID: 26438207
47. Nilssen O, Førde O H. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study. Am J Epidemiol. 1994;139(8):787-792 PMID: 7909980
48. Lee DH, Buijsse B, Steffen L, Holtzman J, Luepker R, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil. 2009;16(1):16-20. doi: 10.1097/HJR.0b013e32830aba5c PMID: 18753951
49. Loomba R, Doycheva I, Bettencourt R, Cohen B, Wassel CL, Brenner D, et al. Serum γ-glutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults. J Clin Exp Hepatol. 2013;3(1):4-11. doi: 10.1016/j.jceh.2012.10.004 PMID: 23997501
50. Uçar H, Gür M, Gözükara MY, Kalkan GY, Baykan AO, Türkoǧlu C, et al. Gamma glutamyl transferase activity is Independently associated with oxidative stress rather than SYNTAX score. Scand J Clin Lab Invest. 2015;75(1):7-12. doi: 10.3109/00365513.2014.954141 PMID: 25180444
51. Emdin M, Passino C, Donato L, Paolicchi A, Pompella A. Serum gamma-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption. Stroke. 2002;33(4):1163-1164. PMID: 11935077
52. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004;109(11):1440-1440. doi: 10.1161/01. CIR.0000120558.41356. E6 PMID: 15037540
53. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease triggering oxidative stress within the plaque. Circulation. 2005;112(14):2078-2080. doi: 10. 1161/CIRCULATIONAHA.105.571919 PMID: 16203922
54. Wickham S, West MB, Cook PF, Hanigan MH. Gamma-glutamyl compounds: substrate specificity of gamma-glutamyl transpeptidase enzymes. Anal Biochem. 2011;414(2):208-14. doi: 10.1016/j.ab. 2011.03.026 PMID: 21447318
55. Angeli V, Tacito A, Paolicchi A, Barsacchi R, Franzini M, Baldassini R, et al. A kinetic study of gammaglutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism. Arch Biochem Biophys. 2009;481(2):191-6. doi: 10.1016/j.abb.2008.10.027 PMID: 19000649
56. Bradley RD, Fitzpatrick AL, Jacobs DR Jr, Lee DH, Swords Jenny N, Herrington D. Associations between γ-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 2014;233(2):387-393. doi: 10.1016/j.atherosclerosis.2014.01. 010 PMID: 24530768
57. Belcastro E, Franzini M, Cianchetti S, Lorenzini E, Masotti S, Fierabracci V, et al. Monocytes/macrophages activation contributes to b-gamma-glutamyltransferase accumulation inside atherosclerotic plaques. J Transl Med. 2015;13(1):1.
58. Çiftçi O, Güllü H, Günday M, Çalişkan M, Kulaksizoǧlu S, Erdoǧan D, Çalişkan Z, et al. Association between serum γ-glutamyltransferase levels and coronary microvascular function. Coron Artery Dis. 2013;24(3):201-8. doi: 10.1097/MCA.0b013e32835e5c86 PMID: 23399927
59. Galderisi M, Cicala S, Caso P, De Simone L, D'Errico A, Petrocelli A, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol. 2002;90(8):860-4. PMID: 12372574
60. Erdogan D, Gullu H, Caliskan M, Yildirim I, Ulus T, Bilgi M, et al. Coronary flow reserve in dipper and non-dipper hypertensive patients. Blood Press. 2005;14(6):345-52. doi: 10.1080/08037050500356550 PMID: 16403688
61. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, et al. The relationship of gamma-glutamyltransferase to C-reactive protein and arterial stiffness. Nutr Metab Cardiovasc Dis. 2008;18(3):211-219. doi: 10.1016/j.numecd.2006.10.002 PMID: 17412574
62. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area A histopathologic correlative study. Circulation. 1995;92(8):2157-2162. PMID: 7554196
63. Mahady SE, Wong G, Turner RM, Mitchell P, Macaskill P, Craig JC, et al. Elevated Liver Enzymes and Mortality in Older Individuals: A Prospective Cohort Study. J Clin Gastroenterol. 2016; [Epub ahead of print].
64. Gjerde H, Amundsen A, Skog OJ, Mørland J, Aasland OG. Serum Gamma-glutamyltransferase: an epidemiological indicator of alcohol consumption?. Br J Addict. 1987;82(9):1027-1031 PMID: 2890368
65. Klatsky A L. Alcohol and cardiovascular diseases: where do we stand today?[J]. J Intern Med. 2015;278(3):238-50. doi: 10.1111/joim.12390 PMID: 26158548
66. Danielsson J, Kangastupa P, Laatikainen T, Aalto M, Niemelä O. Individual and joint impacts of ethanol use, BMI, age and gender on serum gamma-glutamyltransferase levels in healthy volunteers. Int J Mol Sci. 2013;14(6):11929-11941. doi: 10.3390/ijms140611929 PMID: 23736697
67. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765-74. PMID: 1969518
68. Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med. 1985;313(20):1263-9. doi: 10.1056/NEJM198511143132005 PMID: 4058507
69. Ali SS, Oni ET, Blaha MJ, Veledar E, Feiz HR, Feldman T, et al. Elevated gamma-glutamyl transferase is associated with subclinical inflammation independent of cardiometabolic risk factors in an asymptomatic population: a cross-sectional study. Nutr Metab (Lond). 2016;13(1):1.
70. Sinn DH, Cho SJ, Gu S, Seong D, Kang D, Kim H, et al. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis. Gastroenterology. 2016;150(7).